Upfront nilotinib therapy among patients with chronic myeloid leukemia in chronic phase.


Creative Commons License

Eskazan A. E.

Expert opinion on pharmacotherapy, cilt.18, ss.325-326, 2017 (SCI-Expanded, Scopus)